⌘K

Login Start Free

Home/Filings/4/0001209191-21-002503

4//SEC Filing

Pernock David 4

Accession 0001209191-21-002503

CIK 0000827871other

View on SEC.gov Company Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:30 PM ET

Size

4.8 KB

Accession

0001209191-21-002503

Insider Transaction Report

Form 4

Period: 2021-01-05

EAGLE PHARMACEUTICALS, INC.EGRX

Director

Transactions

Tax Payment
Common Stock
2021-01-05$50.02/sh−2,088$104,442→ 47,723 total

Footnotes (1)

[F1]Represents shares withheld to satisfy withholding tax obligations.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1

filerCIK 0001471956

Filing Metadata

Form type: 4
Filed: Jan 6, 7:00 PM ET
Accepted: Jan 7, 4:30 PM ET
Size: 4.8 KB

View on SEC.gov